Noninvasive ventilation in severe hypoxemic respiratory failure
Ferrer 2003 trial design and results
Design
Randomised clinical trial in three hospitals
Treatment
Non-invasive ventilation
Control
High-concentration oxygen therapy
Population
105 patients with severe acute hypoxaemic respiratory failure, excluding hypercapnia
Inclusion criteria
PaO2 60 mmHg or less, or saturation 90% or less, persisting on Venturi oxygen at 50%, without hypercapnia.
Follow-up
90 days
Primary endpoint
Intubation rate
Result
Intubation occurred in 13 of 51 (25%) with non-invasive ventilation versus 28 of 54 (52%) with oxygen (p=0.010). Septic shock occurred in 12% versus 31% (p=0.028) and ICU mortality was 18% versus 39% (p=0.028), with better cumulative 90-day survival (p=0.025). On multivariate analysis non-invasive ventilation was independently associated with lower intubation risk (odds ratio 0.20, p=0.003) and 90-day mortality (odds ratio 0.39, p=0.017).
Secondary endpoints
Septic shock, ICU mortality, 90-day survival, gas exchange
The use of noninvasive ventilation prevented intubation, reduced the incidence of septic shock, and improved survival in these patients compared with high-concentration oxygen therapy.
The trial authors, in the published abstract
How it has aged
A striking early positive result that later trials struggled to reproduce — FLORALI found non-invasive ventilation the worst of its three arms in a similar population. Small, single-country and pre-dating high-flow oxygen entirely, it is best read as the origin of a question rather than its answer.
Publications
Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial
Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003 Dec 15;168(12):1438-44.